214 related articles for article (PubMed ID: 17328943)
1. The clinical significance of anti-prothrombin antibodies for risk assessment of thromboembolism in patients with lupus anticoagulant.
Sailer T; Vormittag R; Zoghlami C; Koder S; Quehenberger P; Male C; Pabinger I
Thromb Res; 2007; 120(2):295-302. PubMed ID: 17328943
[TBL] [Abstract][Full Text] [Related]
2. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T
Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis.
Ishikura K; Wada H; Kamikura Y; Hattori K; Fukuzawa T; Yamada N; Nakamura M; Nobori T; Nakano T
Am J Hematol; 2004 Aug; 76(4):338-42. PubMed ID: 15282665
[TBL] [Abstract][Full Text] [Related]
4. Detecting anti-prothrombin antibodies in young women with acute ischemic stroke.
Cojocaru IM; Cojocaru M; Tănăsescu R; Burcin C; Mitu AC; Iliescu I; Dumitrescu L; Pavel I; Silosi I
Rom J Intern Med; 2008; 46(4):337-41. PubMed ID: 19480300
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of anti-protein Z antibodies in patients with lupus anticoagulant.
Sailer T; Vormittag R; Koder S; Quehenberger P; Kaider A; Pabinger I
Thromb Res; 2008; 122(2):153-60. PubMed ID: 18031797
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies against phosphatidylserine, prothrombin and phosphatidylserine-prothrombin complex: identical or distinct diagnostic tools for antiphospholipid syndrome?
Jaskowski TD; Wilson AR; Hill HR; Branch WD; Tebo AE
Clin Chim Acta; 2009 Dec; 410(1-2):19-24. PubMed ID: 19751711
[TBL] [Abstract][Full Text] [Related]
7. The association of antibodies to cardiolipin, beta 2-glycoprotein I, prothrombin, and oxidized low-density lipoprotein with thrombosis in 292 patients with familial and sporadic systemic lupus erythematosus.
Koskenmies S; Vaarala O; Widen E; Kere J; Palosuo T; Julkunen H
Scand J Rheumatol; 2004; 33(4):246-52. PubMed ID: 15370721
[TBL] [Abstract][Full Text] [Related]
8. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
[TBL] [Abstract][Full Text] [Related]
9. A cross sectional study of antiphospholipid-protein antibodies in patients with venous thromboembolism.
Pasquier E; Amiral J; de Saint Martin L; Mottier D
Thromb Haemost; 2001 Aug; 86(2):538-42. PubMed ID: 11522000
[TBL] [Abstract][Full Text] [Related]
10. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
11. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
Danowski A; Kickler TS; Petri M
J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
[TBL] [Abstract][Full Text] [Related]
12. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
Viveros ME; Cabiedes J; Reyes E; Cabral AR
Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
[TBL] [Abstract][Full Text] [Related]
13. Anti-beta2-glycoprotein I antibodies are associated with pregnancy loss in women with the lupus anticoagulant.
Sailer T; Zoghlami C; Kurz C; Rumpold H; Quehenberger P; Panzer S; Pabinger I
Thromb Haemost; 2006 May; 95(5):796-801. PubMed ID: 16676070
[TBL] [Abstract][Full Text] [Related]
14. Anti-prothrombin antibodies as a potential risk factor of recurrent venous thromboembolism.
Zanon E; Saggiorato G; Ramon R; Girolami A; Pagnan A; Prandoni P
Thromb Haemost; 2004 Feb; 91(2):255-8. PubMed ID: 14961151
[TBL] [Abstract][Full Text] [Related]
15. High titer of anti-phosphatidylserine-prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa.
Kawakami T; Yamazaki M; Mizoguchi M; Soma Y
Arthritis Rheum; 2007 Dec; 57(8):1507-13. PubMed ID: 18050170
[TBL] [Abstract][Full Text] [Related]
16. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
Linnemann B; Schindewolf M; Zgouras D; Erbe M; Jarosch-Preusche M; Lindhoff-Last E
Thromb Res; 2008; 121(6):743-50. PubMed ID: 17804043
[TBL] [Abstract][Full Text] [Related]
17. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects.
Vayá A; Santaolaria M; Micó L; Calvo J; Oropesa R; Villa P; Todoli J; Simó M; Corella D; Ricart JM
Clin Hemorheol Microcirc; 2008; 40(2):79-87. PubMed ID: 19029633
[TBL] [Abstract][Full Text] [Related]
18. Thrombosis in systemic lupus erythematosus: congenital and acquired risk factors.
Afeltra A; Vadacca M; Conti L; Galluzzo S; Mitterhofer AP; Ferri GM; Del Porto F; Caccavo D; Gandolfo GM; Amoroso A
Arthritis Rheum; 2005 Jun; 53(3):452-9. PubMed ID: 15934123
[TBL] [Abstract][Full Text] [Related]
19. Laboratory assessment of hypercoagulable state. A study in a group of patients with venous thromboembolism born in Chioggia.
Gessoni G; Valverde S; Canistro R; Trabuio E; Antico F; Manoni F
Minerva Med; 2007 Apr; 98(2):89-93. PubMed ID: 17519850
[TBL] [Abstract][Full Text] [Related]
20. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
